U.S. Consumer Durables Stock News

With its stock down 45% over the past month, it is easy to disregard AMTD Digital (NYSE:HKD). However, the company's...

AMTD Digital Inc. ( NYSE:HKD ) shareholders won't be pleased to see that the share price has had a very rough month...

Compass Therapeutics (CMPX) has seen a strong move in its shares lately, with returns climbing more than 55% over the past month. Investors are taking note as the stock continues to outperform the broader biotech sector. See our latest analysis for Compass Therapeutics. Compass Therapeutics’ impressive run is not just a short-term blip. The stock’s 1-month share price return of 55% follows an extraordinary 314% gain year-to-date, with momentum clearly building. Over the past year, total...

RBC Capital reinstated coverage on Selective Insurance Group with an 'Outperform' rating on November 25, 2025, following a period without prior coverage from the firm. This new analyst perspective stands out amid a backdrop of varied recommendations for Selective Insurance Group by other institutions in recent months. We'll explore how RBC Capital's return with a positive rating could influence Selective Insurance Group's outlook and its evolving investment narrative. This technology could...

On November 19, 2025, Primerica, Inc. announced a new share repurchase program authorizing the buyback of up to US$475 million of its shares, valid through December 31, 2026. This significant buyback authorization may signal management’s confidence in Primerica’s financial stability and future business outlook to investors. Now, we'll consider how this large-scale repurchase plan could strengthen Primerica’s investment narrative and future earnings assumptions. We've found 15 US stocks that...

In late November 2025, BNP Exane Paribas and Benchmark provided positive analyst commentary on Tencent Music Entertainment Group following significant improvements in its third-quarter results, which featured innovations in content enrichment and expansion of services. A key development was the 20.6% year-over-year increase in revenue from online music services and additional growth in the company's Value-Added Services segment. We'll examine how analyst recognition of Tencent Music's...

StoneX Group (SNEX) has just posted its latest results for FY 2025, reporting $32.3 billion in revenue and basic EPS of $1.67 for the fourth quarter, with net income at $82.6 million. Zooming out, the company has seen rolling twelve-month revenue advance from $98.7 billion to $130.9 billion, while EPS moved from $5.49 to $6.23 over the same span. This represents a 17.4% lift in earnings over the last year. Investors are watching closely as margins show some pressure even as bottom-line growth...

SkyWest (SKYW) drew investor interest after announcing quarterly sales and earnings that topped expectations. The company cited strong travel demand, improved operational efficiency, and growing charter and prorate revenues. Their forward guidance was confident, with expansion and fleet flexibility emphasized. See our latest analysis for SkyWest. After a period of solid momentum earlier this year, SkyWest’s share price has held up well in the last month with a 6.73% gain, even as the past 90...

Oddity Tech Ltd. recently raised its full-year 2025 revenue guidance to a range of US$806 million to US$809 million and introduced METHODIQ, an AI-powered telehealth platform for dermatological care. This combination of increased sales expectations and expansion into the medical telehealth space highlights Oddity Tech’s efforts to diversify its revenue streams and leverage digital health opportunities. We’ll examine how the launch of METHODIQ could influence Oddity Tech’s investment...

Curious whether nVent Electric is a hidden bargain or riding high on momentum? Let’s take a look beneath the surface to see if this stock is truly worth your attention. The share price has experienced notable activity recently, with a 6.7% increase over the last week, some pullback in the past month, and a substantial 56.7% surge year-to-date. This suggests investors may be sensing growth opportunities or reassessing risks. Supporting the stock’s recent narrative are announcements about the...

Curious whether Booz Allen Hamilton Holding shares are now a bargain or still priced for perfection? Let’s break down what’s really happening beneath the surface. Despite climbing 3.3% over the past week, the stock remains deeply in negative territory for the year. It is down 34.9% year-to-date and 42.4% over the last 12 months. These recent price swings have sparked renewed debate, especially after industry news highlighted shifting client spending patterns and the company’s latest contract...

Nordic American Tankers (NAT) just posted its Q3 2025 results, reporting revenue of $45.7 million and a basic EPS of -$0.013. The company has seen revenue fluctuate over recent quarters, moving from $52.0 million in Q3 2024 to $40.2 million in Q2 2025 before rebounding in the latest quarter. Margins remain under pressure, and investors will be watching closely to see if improving EPS forecasts can counter the recent softness in profitability. See our full analysis for Nordic American...

Ever wondered if Southern Copper is worth the price tag? You are not alone. Many investors are asking whether it is undervalued, overvalued, or somewhere in between. The stock has shown big moves lately, jumping 9.0% in the past week and boasting a solid 51.6% gain year-to-date, though it slipped by 3.0% over the last month. Analysts and investors have taken notice as copper prices continue climbing, with the company standing out in recent headlines for strategic investments and expanding...

Imperial Petroleum Inc. recently announced a registered direct offering to institutional investors, issuing 9,523,900 common shares (or pre-funded warrants) with attached Class F and Class G warrants at a combined purchase price of US$6.30 per share and warrants, targeting gross proceeds of approximately US$60.0 million before costs and fees, with closing expected on or about December 1, 2025. This transaction not only infuses substantial new capital into the company for working capital and...

Curious if Newmark Group is still a bargain, or if you’ve missed your moment? Let’s break down whether the current price really tells the full story. The stock has had quite a year, returning 38.6% year-to-date and rising 5.5% in the past week. It has cooled off a little in the past month. Recent headlines around increased commercial real estate activity and high-profile property deals have helped drive investor interest, setting the stage for some of those positive moves. With momentum in...

Element Solutions Inc. recently declared a quarterly cash dividend of US$0.08 per share, to be paid on December 15, 2025, and entered an agreement for a US$450 million add-on to its senior secured term loan B due 2030. These decisions came shortly after reporting third-quarter earnings and revenues above estimates, with the Electronics segment recording an 11% net sales increase and the company reaffirming full-year adjusted EBITDA and free cash flow guidance. We'll consider how Element...

Wondering if Ziff Davis stock is finally trading at a price that makes sense? You are not alone. We are about to break down whether the market might be missing something the numbers reveal. After a rough year with the share price down 44.2% over the past twelve months, Ziff Davis saw a small 3.2% lift in the last week. This could be signaling a turning point, or it may just be a short-term bounce. Investors have been keeping an eye on management changes and Ziff Davis' recent expansion into...

In late November 2025, Citi analyst Michael Rollins resumed coverage of Liberty Broadband, highlighting the company's significant 29% stake in Charter Communications and its discounted valuation, alongside potential for stronger free cash flow generation. This renewed analyst attention underscores growing interest in Liberty Broadband's underlying assets and its positioning for improved financial flexibility. We'll examine how Citi’s renewed coverage and emphasis on Liberty Broadband's...

Brady (BRC) has just released its first quarter earnings, reporting sales of $405 million and net income of $54 million. Both figures are higher than the same period last year, which caught investors’ attention. See our latest analysis for Brady. Brady’s solid Q1 results come after a year of steady progress for shareholders. The share price has climbed 6.4% year-to-date and the total shareholder return over the past year stands at 5.9%. Over the last three years, long-term investors have seen...

Ever wondered whether Kennametal is undervalued or if it is already priced for perfection? If you care about getting the most for your investment dollar, the answer might surprise you. Kennametal has recently caught some attention, rising over 20.9% in the last month alone. It is now up 16.7% year-to-date, which could signal shifting sentiment and fresh opportunity. Much of this momentum follows a flurry of positive industry commentary and renewed demand signals from the manufacturing...

In late November 2025, Tri Pointe Homes reported that its average backlog had fallen 11.2% over the past two years, accompanied by projections of a 17.8% sales decline over the coming year and a 7.5% annual decrease in earnings per share during the same period. This combination of falling backlog, weakening demand projections, and declining profitability highlights operational headwinds likely impacting the company's ability to sustain sales momentum. We'll now explore how ongoing backlog...

If you have ever wondered whether Arrowhead Pharmaceuticals is truly a bargain or just looks like one, you are in the right place. Let’s dig into what the numbers really say about its value. The stock has soared recently, climbing 30.3% in the past week, 24.6% over the past month, and an astonishing 168.2% year-to-date. This suggests that investor optimism and perhaps risk perceptions have shifted quickly. Much of this excitement comes after Arrowhead announced promising clinical trial...

Ultragenyx Pharmaceutical (RARE) captured attention after a recent analyst update on its setrusumab clinical program. This development coincided with reports of strong revenue growth and increasing momentum behind several late-stage drug candidates. See our latest analysis for Ultragenyx Pharmaceutical. Ultragenyx’s recent surge in activity, including clinical milestones and upbeat revenue reports, appears to have lifted investor sentiment. A robust 16% 90-day share price return reflects...

Curious whether Black Stone Minerals is under- or overvalued? Let’s explore what sets the company apart, and why value-focused investors are paying attention to it right now. The stock has been holding steady, returning 0.6% over the last week and rebounding 6.4% over the past month, though it remains down 4.1% year-to-date. Recent headlines have highlighted industry trends influencing energy stocks, and Black Stone Minerals has attracted attention as analysts discuss renewed interest in...